Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
T
200230
vs
K
KOSPI 200
Over the past 12 months, Telcon RF Pharmaceutical Inc has underperformed KOSPI 200, delivering a return of -80% compared to KOSPI 200's +119% growth.
Stocks Performance
200230 vs KOSPI 200
Performance Gap
200230 vs KOSPI 200
Performance By Year
200230 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Telcon RF Pharmaceutical Inc
Glance View
Telcon RF Pharmaceutical is a South Korean drug maker that develops, manufactures, and sells finished medicines. Its products are sold through hospitals, clinics, pharmacies, and pharmaceutical distributors, so the company sits in the part of the healthcare value chain that turns drug formulations into packaged medicines that patients can actually buy and use. The company makes money mainly by selling its own pharmaceutical products, and it may also earn income from contract manufacturing or related supply arrangements if it produces medicines for other firms. That makes it different from a biotech that focuses only on research: Telcon RF Pharmaceutical depends on steady manufacturing, regulatory approval, and sales relationships more than on a single drug discovery bet. For investors, the key idea is that this is a practical, product-based healthcare business. Its results depend on how well it can maintain approvals, keep production reliable, and place its products with medical and distribution channels that move medicines to end users.